Compound Detail
CHEMBL1201230
MAGNESIUM 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL1201230 |
| Name | MAGNESIUM |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | FYYHWMGAXLPEAU-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
3
Publications
1
Known Names
5
Indications
Molecular Properties
24.3
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Pain Uterine Cervical Neoplasms Anemia, Sickle Cell Chemical and Drug Induced Liver Injury Stomatitis
Activity Summary
Ki 1 meas. best 9.62
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 protease CHEMBL243 | Ki | 9.62 | 9.62 | 0.2 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 protease | Ki | = | 0.24 | nM | 9.62 | Inhibition constant of HIV protease inhibitors | 9888839 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 9888839 | 10.1021/jm9803626 | Human immunodeficiency virus type 1 protease | 1 |
| 9888839 | 10.1021/jm9803626 | MT2 | 1 |
Data from ChEMBL 36 via Core Engine